Source: centralcharts

Press Release: Imcyse : DGAP-News: Imcyse SA: Imcyse Reports Positive Immune Response from Interim Analysis of Phase 2 IMPACT Type 1 Diabetes Study

DGAP-News: Imcyse SA / Key word(s): Miscellaneous Imcyse SA: Imcyse Reports Positive Immune Response from Interim Analysis of Phase 2 IMPACT Type 1 Diabetes

Read full article »
Imcyse's Competitors | Imcyse's News | Imcyse's Financials
Stay up-to-date with the latest news on Imcyse
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Denis Bedoret's photo - CEO of Imcyse

CEO

Denis Bedoret

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Imcyse